Most Recent
Biogen to pull MS drug in Australia following encephalitus reports
Healthcare 2018-03-16 11:43 am By Cat Fredenburgh

Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Shine sets sights on new target in pelvic mesh class action
Product Liability 2018-03-08 3:18 pm By Cat Fredenburgh

As Shine Lawyers awaits judgment in a marathon class action against Johnson & Johnson over its pelvic mesh implants, a separate class action by the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

J&J mesh plaintiffs want court OK to expand class
Product Liability 2018-03-07 9:11 pm By Jennifer Cooke

The lead plaintiffs in the class action against Johnson & Johnson over defective pelvic mesh implants said Wednesday they want to expand the size of […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GSK, Novartis concede more ground in ACCC’s Voltaren case
Competition & Consumer Protection 2018-03-06 8:07 pm By Cat Fredenburgh

GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Reckitt Benckiser appeals Nurofen loss
Competition & Consumer Protection 2018-03-05 11:44 am By Cat Fredenburgh

Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

AstraZeneca resolves Crestor patent spat with Generic Health
Intellectual Property 2018-03-01 7:23 pm By Christine Caulfield

Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca’s cholesterol drug Crestor, two-and-a-half years after the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case
Competition & Consumer Protection 2018-02-28 3:47 pm By Christine Caulfield

Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

IP Australia shoots down Bayer patent
Intellectual Property 2018-02-23 8:17 pm By Christine Caulfield

IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer two months to address the patent application’s […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Sanofi wins challenge to Reckitt-Benckiser lozenge patent
Intellectual Property 2018-02-22 7:58 pm By Cat Fredenburgh

The Australian Patent Office has shot down a patent application covering throat lozenges by consumer goods giant Reckitt-Benckiser on a challenge by rival Sanofi-Aventis. Citing […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Lawyers wrap up in J&J vaginal mesh class action
Class Actions 2018-02-22 3:35 pm By Jennifer Cooke

After a marathon six-month hearing over 89 days, closing submissions in the landmark vaginal mesh class action against Johnson & Johnson in the Federal Court […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.